|
BGLC BioNexus Gene Lab Corp 1737523 |
| Balance Sheet |
|
Current Assets
|
$5,195,902.00 |
|
Assets
|
$9,040,130.00 |
|
Current Liabilities
|
$796,470.00 |
|
Liabilities
|
$946,877.00 |
|
Equity
|
$8,093,253.00 |
|
Shares Out
|
2417314.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-147,671.00 |
|
Investing Cash Flow
|
$-13,988.00 |
| Market Analysis |
Market Cap
|
$3,190,854.48 |
|
Price
|
$1.31 |
|
BVPS
|
3.35 |
|
PB
|
0.39 |
|
EPS
|
-0.23 |
|
PS
|
53.71 |
|
FCF
|
$-147,996.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BGLC documents filed with the SEC.
BGLC Filings
Clear
